Parishna Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.80 M
- Company Age 3 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.20 Cr
About Parishna Pharma
Parishna Pharma Private Limited (PPPL) is a Private Limited Indian Non-Government Company incorporated in India on 23 December 2021 (Three years and one month 6 days old ). Its registered office is in Mahesana, Gujarat, India.
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.80 M.
The company currently has active open charges totaling ₹3.20 Cr.
Shaileshkumar Sharma, Tarunaben Sharma, Gautamkumar Patel, and Two other members serve as directors at the Company.
Company Details
- Location
Mahesana, Gujarat, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U24290GJ2021PTC128205
- Company No.
128205
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Dec 2021
- Date of AGM
29 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Parishna Pharma?
Board Members (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shaileshkumar Sharma  | Director | 23-Dec-2021 | Current |
| Tarunaben Sharma | Director | 23-Dec-2021 | Current |
| Gautamkumar Patel | Director | 26-Dec-2022 | Current |
| Hetal Vaishnav | Director | 26-Dec-2022 | Current |
| Vijaykumar Sathwara | Director | 26-Dec-2022 | Current |
Financial Performance of Parishna Pharma.
Enhance accessibility to Parishna Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Parishna Pharma?
Unlock access to Parishna Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹32.00 M
₹0
Charges Breakdown by Lending Institutions
- Canara Bank : 3.20 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 03 Mar 2023 | Canara Bank | ₹3.20 Cr | Open |
How Many Employees Work at Parishna Pharma?
Parishna Pharma has a workforce of 0 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Parishna Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Parishna Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
